Clinical Trials Related to Hoffmann-La Roche

Related studies linked through entity extraction aliases.

A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System

Status: COMPLETED
Phase: PHASE1

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Status: RECRUITING
Phase: PHASE3

A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention

Status: TERMINATED
Phase: PHASE4

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases

Status: UNKNOWN
Phase: N/A

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Status: TERMINATED
Phase: PHASE3

An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction Carcinoma

Status: TERMINATED
Phase: PHASE1/PHASE2

Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

Status: COMPLETED
Phase: PHASE1

A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis

Status: COMPLETED
Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Status: TERMINATED
Phase: PHASE1

A Study To Determine The Effect Of Ocrelizumab On Leptomeningeal Inflammation In Multiple Sclerosis

Status: WITHDRAWN
Phase: PHASE4

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

Status: RECRUITING
Phase: PHASE3

A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma

Status: COMPLETED
Phase: PHASE1

A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE4

Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy

Status: TERMINATED
Phase: PHASE2

A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE2

A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3